版本:
中国

BRIEF-Vertex Pharmaceuticals says FTC requested for additional information on pending acquisition from Concert Pharmaceuticals

May 22 Concert Pharmaceuticals Inc

* Vertex Pharmaceuticals says on May 19, the U.S. FTC issued a request for additional information in connection co's pending acquisition of CTP-656 and other assets from Concert Pharmaceuticals

* The second request was issued under notification requirements of the Hart-Scott-Rodino antitrust improvements act

* Vertex Pharmaceuticals says it intends to work cooperatively with the FTC as it reviews the transaction Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐